HuGE Literature Finder
Records 1-30
|
PPARa, PPARd and PPAR? gene polymorphisms in patients with unstable angina.
Gene 2019 Jun 143947. Maciejewska-Skrendo Agnieszka, Pawlik Andrzej, Sawczuk Marek, Rac Monika, Kusak Andrzej, Safranow Krzysztof, Dziedziejko Violet |
|
Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension.
Diabetes 2019 01 68 (1): 207-219. Ji Yingjie, Yiorkas Andrianos M, Frau Francesca, Mook-Kanamori Dennis, Staiger Harald, Thomas E Louise, Atabaki-Pasdar Naeimeh, Campbell Archie, Tyrrell Jessica, Jones Samuel E, Beaumont Robin N, Wood Andrew R, Tuke Marcus A, Ruth Katherine S, Mahajan Anubha, Murray Anna, Freathy Rachel M, Weedon Michael N, Hattersley Andrew T, Hayward Caroline, Machann Jürgen, Häring Hans-Ulrich, Franks Paul, de Mutsert Renée, Pearson Ewan, Stefan Norbert, Frayling Timothy M, Allebrandt Karla V, Bell Jimmy D, Blakemore Alexandra I, Yaghootkar Hani |
|
PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.
Biomarkers in medicine 2018 Feb . González-Castro Thelma Beatriz, Tovilla-Zárate Carlos Alfonso, Juárez-Rojop Isela Esther, Hernández-Díaz Yazmín, López-Narváez María Lilia, Rodríguez-Pérez Candelario, González-Hernández Yahaira Karina, Ramos-Méndez Miguel Áng |
|
Functional Variant of C-689T in the Peroxisome Proliferator-Activated Receptor-?2 Promoter is Associated with Coronary Heart Disease in Chinese Nondiabetic Han People.
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 2017 Sep 32 (3): 177-184. Li Jian-Ping, Fu Yong-Ping, Chang Wen-Xiu, Yi Chang-Rong, Liu Li-Hua, Xing Hai-Y |
|
Gene-gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese Han Population.
Oncotarget 2017 Mar . Zhang Xiaojiang, Lv Shuzheng, Guo Chengjun, Shi Conghong, Chi Yunpeng, Zhao Lin, Wang Guozhong, Wang Zhishe |
|
Prospective functional classification of all possible missense variants in PPARG.
Nature genetics 2016 Oct . Majithia Amit R, Tsuda Ben, Agostini Maura, Gnanapradeepan Keerthana, Rice Robert, Peloso Gina, Patel Kashyap A, Zhang Xiaolan, Broekema Marjoleine F, Patterson Nick, Duby Marc, Sharpe Ted, Kalkhoven Eric, Rosen Evan D, Barroso Inês, Ellard Sian, , Kathiresan Sekar, , O'Rahilly Stephen, , Chatterjee Krishna, Florez Jose C, Mikkelsen Tarjei, Savage David B, Altshuler Dav |
|
Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Medicine 2016 Aug 95 (32): e4299. Qian Yufeng, Li Peiwei, Zhang Jinjie, Shi Yu, Chen Kun, Yang Jun, Wu Yihua, Ye Xianh |
|
Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
International journal of cardiology 2016 Jul 221 1073-1080. Bielecka-Dabrowa Agata, Sakowicz Agata, Misztal Ma?gorzata, von Haehling Stephan, Ahmed Ali, Pietrucha Tadeusz, Rysz Jacek, Banach Maci |
|
Association of combined genetic variations in PPAR?, PGC-1?, and LXR? with coronary artery disease and severity in Thai population.
Atherosclerosis 2016 Mar 248 140-148. Yongsakulchai Pratthana, Settasatian Chatri, Settasatian Nongnuch, Komanasin Nantarat, Kukongwiriyapan Upa, Cote Michele L, Intharapetch Pongsak, Senthong Vich |
|
Association between Peroxisome Proliferator-activated Receptor Gamma Gene Polymorphisms and Atherosclerotic Diseases: A Meta-analysis of Case-control Studies.
Journal of atherosclerosis and thrombosis 2015 Sep 22 (9): 912-25. Wang Peijian, Wang Qiulin, Yin Yanwei, Yang Zhen, Li Wenzhang, Liang Dengpan, Zhou Pe |
|
Impact of the C1431T Polymorphism of the Peroxisome Proliferator Activated Receptor-Gamma (PPAR-?) Gene on Fasted Serum Lipid Levels in Patients with Coronary Artery Disease.
Annals of nutrition & metabolism 2015 66 (2-3): 149-54. Oladi Mohammadreza, Nohtani Mahdi, Avan Amir, Mirhafez Seyed Reza, Tajbakhsh Amir, Ghasemi Faezeh, Asadi Asadollah, Elahdadi Salmani Mahmoud, Mohammadi Akram, Hoseinzadeh Leila, Ferns Gordon A, Ghayour Mobarhan Maj |
|
PPARG, AGTR1, CXCL16 and LGALS2 polymorphisms are correlated with the risk for coronary heart disease.
International journal of clinical and experimental pathology 2015 8 (3): 3138-43. Tian Jianwei, Hu Shunying, Wang Feng, Yang Xuedong, Li Yuqian, Huang Congch |
|
A Pro 12 Ala substitution in the PPAR?2 polymorphism may decrease the number of diseased vessels and the severity of angiographic coronary artery.
Coronary artery disease 2013 Aug 24 (5): 347-51. Youssef Sarraj Mohamed, Mohamed Najah, Afef Slimani, Khaldoun Ben H, Fadoua Neffati, Fadhel Najjar M, Naceur Slimane |
|
Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
Gene 2013 Jul 523 (1): 20-6. Yilmaz-Aydogan Hulya, Kurnaz Ozlem, Kucukhuseyin Ozlem, Akadam-Teker Basak, Kurt Ozlem, Eronat Allison Pinar, Tekeli Atike, Bugra Zehra, Ozturk Og |
|
The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPAR?) is associated with risk of coronary artery disease: a meta-analysis.
Molecular biology reports 2012 Dec . Wu Z, Lou Y, Jin W, Liu Y, Lu L, Lu G |
|
[Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-gamma2 gene polymorphism].
Terapevticheski? arkhiv 2012 84 (9): 9. Authors are not available |
|
The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis.
Molecular biology reports 2012 Oct . Xu W, Xu J, Sun B, Chen H, Wang Y, Huang F, Xi P, Jiang J |
|
The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Wiener klinische Wochenschrift 2012 Oct 124 (19-20): 671-7. Ding Saidan, Liu Leping, Zhuge Qï-Chuan, Yu Zhen, Zhang Xing, Xie Jieya, Hong Weilong, Wang Silu, Yang Yunxiu, Chen Biche |
|
Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population.
Diabetes research and clinical practice 2012 Sep 97 (3): 483-91. Ho Janice S K, Germer Soren, Tam Claudia H T, So Wing-Yee, Martin Mitchell, Ma Ronald C W, Chan Juliana C N, Ng Maggie C |
Genome-wide association study for circulating levels of plasminogen activator inhibitor-1 (PAI-1) provides novel insights into the regulation of PAI-1.
Blood 2012 Sep . Huang J, Sabater-Lleal M, Asselbergs FW, Tregouet D, Shin SY, Ding J, Baumert J, Oudot-Mellakh T, Folkersen L, Johnson AD, Smith NL, Williams SM, Ikram MA, Kleber ME, Becker DM, Truong V, Mychaleckyj JC, Tang W, Yang Q, Sennblad B, Moore JH, Williams FM, Dehghan A, Silbernagel G, Schrijvers EM, Smith S, Karakas M, Tofler GH, Silveira A, Navis GJ, Lohman K, Chen MH, Peters A, Goel A, Hopewell JC, Chambers JC, Saleheen D, Lundmark P, Psaty BM, Strawbridge RJ, Boehm BO, Carter AM, Meisinger C, Peden JF, Bis JC, McKnight B, Ohrvik J, Taylor K, Franzosi MG, Seedorf U, Collins R, Franco-Cereceda A, Syvänen AC, Goodall AH, Yanek LR, Cushman M, Müller-Nurasyid M, Folsom AR, Basu S, Matijevic N, van Gilst WH, Kooner JS, Hofman A, Danesh J, Clarke R, Meigs JB, Consortium D, Kathiresan S, Reilly MP, Consortium C, Klopp N, Harris TB, Winkelmann BR, Grant PJ, Hillege HL, Watkins H, Consortium CF, Spector TD, Becker LC, Tracy RP, März W, Uitterlinden AG, Eriksson P, Cambien F, Consortium C, Morange PE, Koenig W, Soranzo N, van der Harst P, Liu Y, O'Donnell CJ, Hamsten A |
|
Association between C1431T polymorphism in peroxisome proliferator-activated receptor-? gene and coronary artery disease in Chinese Han population.
Molecular biology reports 2012 Feb 39 (2): 1863-8. Zhou Xiang, Chen Jianchang, Xu Weiti |
|
Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.
Genetic testing and molecular biomarkers 2012 Feb 16 (2): 134-7. Aydo?an Hülya Yilmaz, Küçükhüseyin Ozlem, Tekeli Atike, Isbir Turg |
|
Association between PPAR?2 Pro12Ala polymorphism and myocardial infarction and obesity in Han Chinese in Hohhot, China.
Genetics and molecular research : GMR 2012 11 (3): 2929-38. Wang L P, Zhao L R, Cui H W, Yan M R, Yang L, Su X |
|
The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPAR?2) is associated with increased risk of coronary artery disease: a meta-analysis.
PloS one 2012 7 (12): e53105. Wu Zhijun, Lou Yuqing, Jin Wei, Liu Yan, Lu Lin, Lu Guopi |
|
Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
Molecular and cellular biochemistry 2011 Dec 358 (1-2): 355-63. Yilmaz-Aydogan Hulya, Kurnaz Ozlem, Kurt Ozlem, Akadam-Teker Basak, Kucukhuseyin Ozlem, Tekeli Atike, Isbir Turg |
|
Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI.
Atherosclerosis 2011 Aug 217 (2): 458-64. Peters Bas J M, Pett Helmi, Klungel Olaf H, Stricker Bruno H Ch, Psaty Bruce M, Glazer Nicole L, Wiggins Kerri L, Bis Josh C, de Boer Anthonius, Maitland-van der Zee Anke-Hil |
|
The 1p13.3 LDL (C)-associated locus shows large effect sizes in young populations.
Pediatric research 2011 Jun 69 (6): 538-43. Devaney Joseph M, Thompson Paul D, Visich Paul S, Saltarelli William A, Gordon Paul M, Orkunoglu-Suer E Funda, Gordish-Dressman Heather, Harmon Brennan T, Bradbury Margaret K, Panchapakesan Karuna, Khianey Rahul, Hubal Monica J, Clarkson Priscilla M, Pescatello Linda S, Zoeller Robert F, Moyna Niall M, Angelopoulos Theodore J, Kraus William E, Hoffman Eric |
|
Genetic variants of diabetes risk and incident cardiovascular events in chronic coronary artery disease.
PloS one 2011 6 (1): e16341. Sousa André Gustavo P, Lopes Neuza H, Hueb Whady A, Krieger José Eduardo, Pereira Alexandre |
|
Relationship of APOA5, PPAR? and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood.
Lipids in health and disease 2011 10 (1): 68. Ramakrishnan Lakshmy, Sachdev Harshpal S, Sharma Meenakshi, Abraham Ransi, Prakash Swami, Gupta Dileep, Singh Yogendra, Bhaskar Seema, Sinha Shikha, Chandak Giriraj R, Reddy Kolli S, Santosh Bharga |
|
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.
Journal of lipid research 2010 Dec 51 (12): 3524-32. Peloso Gina M, Demissie Serkalem, Collins Dorothea, Mirel Daniel B, Gabriel Stacey B, Cupples L Adrienne, Robins Sander J, Schaefer Ernst J, Brousseau Margaret |
|
Coronary artery calcification and its relationship to validated genetic variants for diabetes mellitus assessed in the Heinz Nixdorf recall cohort.
Arteriosclerosis, thrombosis, and vascular biology 2010 Sep 30 (9): 1867-72. Pechlivanis Sonali, Scherag André, Mühleisen Thomas W, Möhlenkamp Stefan, Horsthemke Bernhard, Boes Tanja, Bröcker-Preuss Martina, Mann Klaus, Erbel Raimund, Jöckel Karl-Heinz, Nöthen Markus M, Moebus Susanne, |
|
Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population.
Journal of human genetics 2010 Aug 55 (8): 490-4. Wang Ying, Fu Wenqing, Xie Fang, Wang Yi, Chu Xun, Wang Haifeng, Shen Min, Wang Ying, Wang Yi, Sun Weiwei, Lei Rong, Yang Lin, Wu Hong, Foo Jianee, Liu Jianjun, Jin Li, Huang W |
|
Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population.
Heart and vessels 2010 May 25 (3): 229-36. Nikitin Alexey G, Chistiakov Dimitry A, Minushkina Larissa O, Zateyshchikov Dmitry A, Nosikov Valery |
|
Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes--an 8-year prospective cohort analysis of 1297 patients.
Diabetic medicine : a journal of the British Diabetic Association 2010 Apr 27 (4): 376-83. Wang Y, Luk A O Y, Ma R C W, So W Y, Tam C H T, Ng M C Y, Yang X, Baum L, Lam V, Tong P C Y, Chan J C |
|
Associations for lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in an Indian population.
Archives of medical research 2010 Jan 41 (1): 19-25.e1. AshokKumar Manickaraj, Veera Subhashini Navaneethan Gnana, Kanthimathi Sekar, SaiBabu Ramineni, Ramesh Arabandi, Cherian Kotturathu Mammen, Emmanuel Cyr |
|
+294T/C polymorphism in the PPAR-delta gene is associated with risk of coronary artery disease in normolipidemic Tunisians.
Genetics and molecular research : GMR 2010 9 (3): 1326-33. Jguirim-Souissi I, Jelassi A, Hrira Y, Najah M, Slimani A, Addad F, Hassine M, Hamda K B, Maatouk F, Rouis M, Slimane M |
|
Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function.
BMC medical genetics 2010 11 (1): 65. Juang Jyh-Ming Jimmy, de Las Fuentes Lisa, Waggoner Alan D, Gu C Charles, Dávila-Román Víctor |
|
Homozygosity for the Ala allele of the PPAR?2 Pro12Ala polymorphism is associated with reduced risk of coronary artery disease.
Disease markers 2010 29 (5): 259-64. Galgani Andrea, Valdes AnaMaria, Erlich Henry A, Mano Calvin, Cheng Suzanne, Petrone Antonio, Sentinelli Federica, Berni Andrea, Baroni Marco G, Buzzetti Raffael |
|
PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.
Cardiovascular diabetology 2010 9 (1): 13. Wan Jing, Xiong Shixi, Chao Shengping, Xiao Jianming, Ma Yexin, Wang Jinghua, Roy Sabi |
|
Integrative predictive model of coronary artery calcification in atherosclerosis.
Circulation 2009 Dec 120 (24): 2448-54. McGeachie Michael, Ramoni Rachel L Badovinac, Mychaleckyj Josyf C, Furie Karen L, Dreyfuss Jonathan M, Liu Yongmei, Herrington David, Guo Xiuqing, Lima João A, Post Wendy, Rotter Jerome I, Rich Stephen, Sale Michèle, Ramoni Marco |
|
Nuclear receptors gene polymorphisms and risk of restenosis and clinical events following coronary stenting.
Vnitr?ní lékar?ství 2009 Dec 55 (12): 1135-40. Neugebauer P, Goldbergová-Pávková M, Kala P, Bocek O, Jerábek P, Poloczek M, Vytiska M, Parenica J, Mikulík R, Jarkovský J, Semrád B, Spinar J, Vask? |
|
PPARgamma promoter polymorphisms and acute coronary syndrome.
Atherosclerosis 2009 Jul 205 (1): 186-91. Evangelisti L, Attanasio M, Lucarini L, Sofi F, Marcucci R, Giglioli C, Valente S, Gensini Gf, Abbate R, Pepe |
|
The Proline 12 Alanine Substitution in the PPARgamma2 Gene is Associated With Increased Extent of Coronary Artery Disease in Men.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009 Jun . Schneider JG, Schiekofer S, Eynatten MV, Schlimmer P, Dugi KA |
|
PPAR gamma variant influences angiographic outcome and 10-year cardiovascular risk in male symptomatic coronary artery disease patients.
Diabetes care 2009 May 32 (5): 839-44. Regieli Jakub J, Jukema J Wouter, Doevendans Pieter A, Zwinderman Aeilko H, van der Graaf Yolanda, Kastelein John J, Grobbee Diederick |
|
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.
BMC medical genetics 2009 10 (1): 111. Chen Suet Nee, Cilingiroglu Mehmet, Todd Josh, Lombardi Raffaella, Willerson James T, Gotto Antonio M, Ballantyne Christie M, Marian A |
|
PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.
BMC medical genetics 2009 10 (1): 52. Vogel Ulla, Segel Stine, Dethlefsen Claus, Tjønneland Anne, Saber Anne Thoustrup, Wallin Håkan, Jensen Majken K, Schmidt Erik B, Andersen Paal Skytt, Overvad K |
|
Genetic variants associated with insulin resistance and metabolic syndrome in young Asian Indians with myocardial infarction.
Metabolic syndrome and related disorders 2008 Sep 6 (3): 209-14. Ranjith Naresh, Pegoraro Rosemary J, Naidoo Datshana P, Shanmugam Rebecca, Rom L |
|
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.
American journal of human genetics 2008 Apr 82 (4): 809-21. Merner Nancy D, Hodgkinson Kathy A, Haywood Annika F M, Connors Sean, French Vanessa M, Drenckhahn Jörg-Detlef, Kupprion Christine, Ramadanova Kalina, Thierfelder Ludwig, McKenna William, Gallagher Barry, Morris-Larkin Lynn, Bassett Anne S, Parfrey Patrick S, Young Terry-Ly |
|
[Study on the association of -689C/T polymorphism in the PPARgamma2 promoter with myocardial infarction].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2008 Feb 25 (1): 19-22. Li Jian-ping, Cheng Long-xian, He Mei-an, Wu Tang-ch |
|
Investigation of 89 candidate gene variants for effects on all-cause mortality following acute coronary syndrome.
BMC medical genetics 2008 9 66. Morgan Thomas M, Xiao Lan, Lyons Patrick, Kassebaum Bethany, Krumholz Harlan M, Spertus John |
|
Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses.
Vascular health and risk management 2008 4 (2): 427-36. Zafarmand Mohammad Hadi, van der Schouw Yvonne T, Grobbee Diederick E, de Leeuw Peter W, Bots Michiel |
|
Ala12 variant of the peroxisome proliferator-activated receptor-gamma gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction.
The American journal of clinical nutrition 2007 Oct 86 (4): 1238-42. Ruiz-Narváez Edward A, Kraft Peter, Campos Hann |
|
PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.
American heart journal 2007 Oct 154 (4): 718-24. Liu Yu, Yuan Zuyi, Liu Yan, Zhang Jijun, Yin Ping, Wang Dongqi, Wang Yanni, Kishimoto Chiharu, Ma Aiq |
|
High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Arteriosclerosis, thrombosis, and vascular biology 2007 Apr 27 (4): 923-8. Nohara Atsushi, Kawashiri Masa-aki, Claudel Thierry, Mizuno Mihoko, Tsuchida Masayuki, Takata Mutsuko, Katsuda Shoji, Miwa Kenji, Inazu Akihiro, Kuipers Folkert, Kobayashi Junji, Koizumi Junji, Yamagishi Masakazu, Mabuchi Hiros |
|
No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects.
Circulation journal : official journal of the Japanese Circulation Society 2007 Mar 71 (3): 338-42. Rhee Eun Jung, Kwon Chang Hee, Lee Won Young, Kim Se Yeon, Jung Chan Hee, Kim Byung Jin, Sung Ki Chul, Kim Bum Soo, Oh Ki Won, Kang Jin Ho, Park Sung Woo, Kim Sun Woo, Lee Man Ho, Park Jung R |
|
Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007 45 (8): 962-7. Wang Shuxia, Fu Chunyan, Wang Hu, Shi Yi, Xu Xiqi, Chen Jingzhou, Song Xiaodong, Sun Kai, Wang Jianwei, Fan Xiaohan, Wang Hongjian, Yang Xiaomin, Huan Tujun, Hui Rut |
|
Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population.
Clinical cardiology 2006 Jul 29 (7): 300-4. Li Lin, Cheng Long-Xian, Nsenga Ripen, He Mei-An, Wu Tang-Ch |
|
Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model.
Clinical biochemistry 2006 Feb 39 (2): 109-14. Nassar Bassam A, Rockwood Kenneth, Kirkland Susan A, Ransom Thomas P, Darvesh Sultan, MacPherson Kathleen, Johnstone David E, O'Neill Blair J, Bata Iqbal R, Andreou Pantelis, Jeffery Julie S, Cox Jafna L, Title Lawrence |
|
Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis.
Journal of thrombosis and haemostasis : JTH 2006 Feb 4 (2): 341-8. Zee R Y L, Cook N R, Cheng S, Erlich H A, Lindpaintner K, Ridker P |
|
Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women.
Arteriosclerosis, thrombosis, and vascular biology 2005 Aug 25 (8): 1654-8. Pischon Tobias, Pai Jennifer K, Manson JoAnn E, Hu Frank B, Rexrode Kathryn M, Hunter David, Rimm Eric |
|
Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study.
Arteriosclerosis, thrombosis, and vascular biology 2004 Dec 24 (12): 2403-7. Doney Alex S F, Fischer Bettina, Leese Graham, Morris Andrew D, Palmer Colin N |
|
The 161TT genotype in the exon 6 of the peroxisome-proliferator-activated receptor gamma gene is associated with premature acute myocardial infarction and increased lipid peroxidation in habitual heavy smokers.
Clinical science (London, England : 1979) 2004 Nov 107 (5): 461-6. Chao Ting-Hsing, Li Yi-Heng, Chen Jyh-Hong, Wu Hua-Lin, Shi Guey-Yueh, Liu Ping-Yen, Tsai Wei-Chuan, Guo How-R |
|
Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study.
Pharmacogenetics 2004 Jan 14 (1): 61-71. Chen Suetnee, Tsybouleva Natalia, Ballantyne Christie M, Gotto Antonio M, Marian A |
|
[Genetic Predictors of Unfavorable Course in High Risk Patients With Ischemic Heart Disease. Data of Follow-up for Two Years.].
Kardiologiia 2004 44 (12): 16-22. Zate?shchikov D A, Chumakova O S, Zate?shchikova A A, Zotova I V, Minushkina L O, Chudakova D A, Nosikov V V, Sidorenko B |
|
Gene-gene interaction of PPARgamma and ApoE affects coronary heart disease risk.
International journal of cardiology 2003 Dec 92 (2-3): 257-63. Peng Dao-Quan, Zhao Shui-Ping, Nie Sai, Li Jia |
|
Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.
Arteriosclerosis, thrombosis, and vascular biology 2003 May 23 (5): 859-63. Ridker Paul M, Cook Nancy R, Cheng Suzanne, Erlich Henry A, Lindpaintner Klaus, Plutzky Jorge, Zee Robert Y |
|
[Genetic predictors of left ventricular hypertrophy: do polymorphisms of peroxisome proliferator activated nuclear receptor genes play any role?].
Kardiologiia 2003 43 (12): 71-5. Minushkina L O, Brazhnik V A, Zate?shchikov D A, Ignat'ev I V, Nosikov V V, Sidorenko B |
|
Lack of association between peroxisome proliferator-activated receptor-gamma-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus.
European journal of endocrinology / European Federation of Endocrine Societies 2002 Apr 146 (4): 545-51. Blüher M, Klemm T, Gerike T, Krankenberg H, Schuler G, Paschke |
|
The proline 12 alanine substitution in the peroxisome proliferator--activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo.
Diabetes 2002 Mar 51 (3): 867-70. Schneider Jochen, Kreuzer Joerg, Hamann Andreas, Nawroth Peter P, Dugi Klaus |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: